{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:23:42Z","timestamp":1787869422186,"version":"build-2784847793"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YCJJ20252106"],"award-info":[{"award-number":["YCJJ20252106"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.critrevonc.2026.105409","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:02:27Z","timestamp":1780300947000},"page":"105409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dendritic cell-driven immune rebalancing as a systemic regulator of tumor and neurodegenerative microenvironments"],"prefix":"10.1016","volume":"225","author":[{"given":"Peng-Yu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Lin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8011-2405","authenticated-orcid":false,"given":"Wei-Lin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9206-1203","authenticated-orcid":false,"given":"Wioletta","family":"Rozp\u0119dek-Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105409_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-immunol-090122-041105","article-title":"Ontogeny and function of plasmacytoid dendritic cells","volume":"42","author":"Adams","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.critrevonc.2026.105409_bib3","doi-asserted-by":"crossref","DOI":"10.48101\/ujms.v129.10627","article-title":"Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells","volume":"129","author":"Badillo","year":"2024","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105409_bib4","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105409_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89530","article-title":"ALS patients\u2019 regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity","volume":"2","author":"Beers","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2026.105409_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161849","article-title":"The value of Interferon \u03b2 in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review","volume":"14","author":"Bellucci","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(25)00262-4","article-title":"Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole in amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled phase 2b trial","author":"Bensimon","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2026.105409_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf4726","article-title":"Architects of immunity: how dendritic cells shape CD8+ T cell fate in cancer","volume":"10","author":"Bhandarkar","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.it.2022.12.006","article-title":"Life and death of tolerogenic dendritic cells","volume":"44","author":"Bourque","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011119","article-title":"Role of high-dose interleukin-2 for melanoma in the age of cellular therapy","volume":"13","author":"Buchbinder","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105409_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","article-title":"Dendritic cells revisited","volume":"39","author":"Cabeza-Cabrerizo","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/WCO.0000000000001279","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications","volume":"37","author":"Calma","year":"2024","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101710","article-title":"MHC-dressing on dendritic cells: boosting anti-tumor immunity via unconventional tumor antigen presentation","volume":"66","author":"Chatterjee","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib14","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1038\/s41467-025-60927-7","article-title":"Engineering STING nanoadjuvants for spatiotemporally-tailored innate immunity stimulation and cancer vaccination therapy","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105409_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105409_bib16","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2147\/DDDT.S501773","article-title":"Regulation and function of the cGAS-STING pathway: mechanisms, post-translational modifications, and therapeutic potential in immunotherapy","volume":"19","author":"Chen","year":"2025","journal-title":"Drug. Des. Dev. Ther."},{"key":"10.1016\/j.critrevonc.2026.105409_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40035-025-00517-1","article-title":"Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications","volume":"14","author":"Chen","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.critrevonc.2026.105409_bib18","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105409_bib19","article-title":"Dendritic cell immunotherapy advances for solid tumors: vaccination and modulation","volume":"6","author":"Clayton","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.critrevonc.2026.105409_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105409_bib21","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in thE Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105409_bib22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","article-title":"ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis","volume":"161","author":"Cubillos-Ruiz","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105409_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2024.106905","article-title":"Research progress in the mechanisms and functions of specialized pro-resolving mediators in neurological diseases","volume":"175","author":"Deng","year":"2024","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.critrevonc.2026.105409_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s42003-022-03169-3","article-title":"Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F\/NL-G-F mice","volume":"5","author":"Emre","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112648","article-title":"ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activation","volume":"28","author":"Evangelista","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.critrevonc.2026.105409_bib27","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/s41593-024-01774-5","article-title":"Integrated multimodal cell atlas of Alzheimer\u2019s disease","volume":"27","author":"Gabitto","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.critrevonc.2026.105409_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-024-07671-y","article-title":"Plasmacytoid dendritic cells control homeostasis of megakaryopoiesis","volume":"631","author":"Gaertner","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105409_bib29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3389\/fimmu.2020.00924","article-title":"Dendritic cells and their role in immunotherapy","volume":"11","author":"Gardner","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105409_bib31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","article-title":"Therapeutic targeting of the complement system: from rare diseases to pandemics","volume":"73","author":"Garred","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.critrevonc.2026.105409_bib32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.it.2019.06.004","article-title":"Dendritic cell metabolism and function in tumors","volume":"40","author":"Giovanelli","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fimmu.2014.00007","article-title":"Regulatory dendritic cells for immunotherapy in immunologic diseases","volume":"5","author":"Gordon","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105409_bib35","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.3390\/ijms26125444","article-title":"The Design of a multistage monitoring protocol for dendritic cell-derived exosome (DEX) immunotherapy: a conceptual framework for molecular quality control and immune profiling","volume":"26","author":"Guti\u00e9rrez-Sandoval","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105409_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105409_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.2022045080","article-title":"Regulatory T cell therapeutics for neuroinflammatory disorders","volume":"42","author":"Harkins","year":"2022","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib39","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8\u03b1+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105409_bib40","doi-asserted-by":"crossref","first-page":"0948","DOI":"10.34133\/research.0948","article-title":"Chronic psychological stress in oncogenesis: multisystem crosstalk and multimodal interventions","author":"Huang","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.critrevonc.2026.105409_bib41","first-page":"15","article-title":"A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis","author":"Jr","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103067","article-title":"A mechanism of cooling hot tumors: lactate attenuates inflammation in dendritic cells","volume":"24","author":"Kanemaru","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.critrevonc.2026.105409_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123893","article-title":"Programmable bacteria-driven biohybrid triggers spatiotemporal-controlled STING activation to potentiate cuproptosis-based cancer therapy","volume":"328","author":"Kang","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105409_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41577-023-00970-x","article-title":"Therapeutic induction of antigen-specific immune tolerance","volume":"24","author":"Kenison","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41586-024-08279-y","article-title":"Endogenous self-peptides guard immune privilege of the central nervous system","volume":"637","author":"Kim","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105409_bib46","volume":"12","author":"Lau","year":"2022","journal-title":"BMJ Open."},{"key":"10.1016\/j.critrevonc.2026.105409_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2024.12.005","article-title":"Type 2 conventional dendritic cell functional heterogeneity: ontogenically committed or environmentally plastic?","volume":"46","author":"Le\u00f3n","year":"2025","journal-title":"Trends Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib48","article-title":"Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy","volume":"5","author":"Liu","year":"2024","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.critrevonc.2026.105409_bib49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00018-023-04932-3","article-title":"Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming","volume":"80","author":"Liu","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105409_bib50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13063-025-08972-x","volume":"26","author":"Long","year":"2025","journal-title":"Trials"},{"key":"10.1016\/j.critrevonc.2026.105409_bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fphar.2019.00395","article-title":"Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer\u2019s disease through activation of BDNF-TrkB signaling pathway","volume":"10","author":"Luo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib52","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s12276-025-01465-6","article-title":"Extracellular vesicles derived from lung M2 macrophages enhance group 2 innate lymphoid cells function in allergic airway inflammation","volume":"57","author":"Lv","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105409_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-020-00375-7","article-title":"Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders","volume":"15","author":"Machhi","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.critrevonc.2026.105409_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/science.adh4567","article-title":"Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer","volume":"384","author":"Mahadevan","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105409_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13024-022-00525-z","article-title":"The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS\/FTD","volume":"17","author":"Masrori","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.critrevonc.2026.105409_bib56","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41590-024-01745-9","article-title":"Distinct ontogenetic lineages dictate cDC2 heterogeneity","volume":"25","author":"Minutti","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib57","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1038\/s41588-024-01961-x","article-title":"Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer\u2019s disease","volume":"56","author":"Miyoshi","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2026.105409_bib58","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41423-021-00753-1","article-title":"Metabolic programming in dendritic cells tailors immune responses and homeostasis","volume":"19","author":"M\u00f8ller","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105409_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101848","article-title":"Antigen cross-presentation by dendritic cells: a critical axis in cancer immunotherapy","volume":"71","author":"Moussion","year":"2024","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib61","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/s12276-025-01527-9","article-title":"Targeting immunosenescence and inflammaging: advancing longevity research","volume":"57","author":"Nguyen","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105409_bib62","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S2213-8587(20)30104-2","article-title":"Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes","volume":"8","author":"Nikolic","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101711","article-title":"The evolving biology of cross-presentation","volume":"66","author":"Ohara","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib64","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.ccell.2025.07.013","article-title":"Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer","volume":"43","author":"Osorio","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105409_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omae201","article-title":"PD-1\/PD-L1 checkpoint inhibitor-induced encephalitis in patients with lung adenocarcinoma: a report of three cases","volume":"2025","author":"Ota","year":"2025","journal-title":"Oxf. Med. Case Rep."},{"key":"10.1016\/j.critrevonc.2026.105409_bib66","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105409_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613492","article-title":"Metabolism of dendritic cells in tumor microenvironment: for immunotherapy","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib68","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature22367","article-title":"Chromatin states define tumour-specific T cell dysfunction and reprogramming","volume":"545","author":"Philip","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105409_bib69","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.3390\/ijms22137144","article-title":"Regulatory T cells-related genes are under DNA methylation influence","volume":"22","author":"Piotrowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105409_bib70","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn.4475","article-title":"The role of peripheral immune cells in the CNS in steady state and disease","volume":"20","author":"Prinz","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.critrevonc.2026.105409_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003284","article-title":"Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response","volume":"23","author":"Qiu","year":"2025","journal-title":"PLoS Biol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib72","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/2326-6066.CIR-15-0210","article-title":"PD-1 blockade expands intratumoral memory T cells","volume":"4","author":"Ribas","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105409_bib73","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105409_bib74","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221929","article-title":"Age-related alterations in meningeal immunity drive impaired CNS lymphatic drainage","volume":"220","author":"Rustenhoven","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.critrevonc.2026.105409_bib75","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/biomedicines13092167","article-title":"Intrathecal therapies for neurodegenerative diseases: a review of current approaches and the urgent need for advanced delivery systems","volume":"13","author":"Schreiner","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2026.105409_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70075","article-title":"Monocyte-derived dendritic cells: an updated view on an old concept","volume":"336","author":"Segura","year":"2025","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.critrevonc.2026.105409_bib77","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.celrep.2019.09.089","article-title":"Magnitude of therapeutic STING activation determines CD8+ T cell-mediated anti-tumor immunity","volume":"29","author":"Sivick","year":"2019","journal-title":"Cell. Rep."},{"key":"10.1016\/j.critrevonc.2026.105409_bib78","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1073\/pnas.75.10.5132","article-title":"Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice","volume":"75","author":"Steinman","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2026.105409_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113392","article-title":"Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies","volume":"144","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101605","article-title":"Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions","volume":"33","author":"Suuring","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.critrevonc.2026.105409_bib81","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200019","article-title":"Combined regulatory T-lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis","volume":"9","author":"Thonhoff","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.critrevonc.2026.105409_bib82","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105409_bib83","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2017.10.022","article-title":"Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer","volume":"171","author":"Topper","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105409_bib84","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib85","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/s41467-017-02186-9","article-title":"Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer","volume":"8","author":"Veglia","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105409_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109758","article-title":"Dendritic cell-expressed IDO alleviates atherosclerosis by expanding CD4+CD25+Foxp3+Tregs through IDO-Kyn-AHR axis","volume":"116","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578290","article-title":"Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson\u2019s disease: A Systematic review and meta-analysis","volume":"388","author":"Wang","year":"2024","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib88","doi-asserted-by":"crossref","first-page":"12223","DOI":"10.3390\/ijms252212223","article-title":"Metabolic reprogramming of immune cells in the tumor microenvironment","volume":"25","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105409_bib89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib90","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41423-021-00791-9","article-title":"Metabolism of tissue macrophages in homeostasis and pathology","volume":"19","author":"Wculek","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1140765","article-title":"Insights into dendritic cell maturation during infection with application of advanced imaging techniques","volume":"13","author":"Xiao","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib92","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41531-024-00790-3","article-title":"Single-cell RNA sequencing reveals peripheral immunological features in Parkinson\u2019s disease","volume":"10","author":"Xiong","year":"2024","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.critrevonc.2026.105409_bib93","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","article-title":"T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression","volume":"13","author":"Yazdani","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105409_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.872134","article-title":"The emerging role of central and peripheral immune systems in neurodegenerative diseases","volume":"14","author":"Zang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.critrevonc.2026.105409_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1490129","article-title":"Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib96","article-title":"Transcriptional regulation of dendritic cell development and function","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105409_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106710","article-title":"The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellular and molecular mechanisms in neurodegenerative diseases","volume":"202","author":"Zhang","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.critrevonc.2026.105409_bib98","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-025-09000-3","article-title":"STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity","volume":"643","author":"Zhou","year":"2025","journal-title":"Nature"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:52:39Z","timestamp":1787107959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826002969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":98,"alternative-id":["S1040842826002969"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105409","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cell-driven immune rebalancing as a systemic regulator of tumor and neurodegenerative microenvironments","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105409"}}